In this document, PATH seeks to synthesize primary scientific literature, technology landscape analyses, and drug development principles to describe key considerations related to the diagnosis and control of schistosomiasis and outline a business case for financing, developing, and deploying new diagnostics for detection of Schistosoma infection.